--- 
layout: page 
image:
  feature: DaubEnginePatent.jpg
--- 
   <head>
      <title>2132-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-2100.html"><span>Chapter 2100</span></a></li>
      <li><span>Section 2132</span></li>  </ul>  </div>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e203390">
                     <h1 class="page-title">2132
                        &nbsp;&nbsp;
                        Pre-AIA 35 U.S.C. 102(a)  [R-11.2013]
                     </h1>
                     <p id="ch2100_d222e6_18b11_12a"><i>[Editor Note: This MPEP section is
                           <b id="">not applicable</b> to applications subject to examination under the first
                           inventor to file (FITF) provisions of the AIA as set forth in <b><a href="mpep-9015-appx-l.html#al_d1d917_1bef1_2b">35 U.S.C. 100
                                 (note)</a></b>. See <b><a href="s2159.html#ch2100_d20034_1dc34_1dd">MPEP § 2159</a></b> et seq. to determine
                           whether an application is subject to examination under the FITF provisions, and
                           <b><a href="s2150.html#ch2100_d2002f_22805_16e">MPEP §
                                 2150</a></b> et seq. for examination of applications subject to those
                           provisions. See <b><a href="s2152.html#ch2100_d20033_18e23_3ce">MPEP § 2152</a></b> et seq. for a detailed
                           discussion of <b><a href="mpep-9015-appx-l.html#al_d1fbe1_234ed_52">AIA 35 U.S.C. 102(a) and (b)</a></b>.]</i></p>
                     <div id="d0e203394" class="USC">
                        <h4 class="USC"><i>Pre-AIA 35&nbsp;U.S.C.&nbsp;102 &nbsp;
                              
                              
                              
                              Conditions for patentability; novelty and loss of right to
                              patent.</i></h4>
                        <p id="d0e203398">A person shall be entitled to a patent unless
                           -
                        </p>
                        <ul style="list-style-type: none;">
                           <li id="d0e203402" class="nobull">(a) the invention was known or used by others in this
                              country, or patented or described in a printed publication in this or a foreign
                              country, before the invention thereof by the applicant for a
                              patent.
                           </li>
                        </ul>
                        <p class="excludedText"> ***** 
                           
                        </p>
                     </div>
                     <div class="Section">
                        <h2 class="section1" id="d0e203408">I.
                           &nbsp;&nbsp;“KNOWN OR USED”
                        </h2>
                        <div class="Section">
                           <h2 class="section2" id="d0e203412">A.
                              &nbsp;&nbsp;“Known or Used” Means Publicly Known or Used
                           </h2>
                           <p id="d0e203416">“The statutory language ‘known or used by others in this
                              country’ [<b><a href="mpep-9015-appx-l.html#d0e302391">pre-AIA
                                    35 U.S.C. 102(a)</a></b>], means knowledge or use which is accessible
                              to the public.” <i>Carella</i><i>v. Starlight Archery, </i>804 F.2d 135, 231 USPQ 644
                              (Fed. Cir. 1986). The knowledge or use is accessible to the public if there has been
                              no deliberate attempt to keep it secret. <i>W. L. Gore &amp;
                                 Assoc</i>. <i>v.</i><i>Garlock, Inc.,</i> 721 F.2d 1540, 220 USPQ 303 (Fed.
                              Cir. 1983).
                           </p>
                           <p id="d0e203434">See <b><a href="s2128.html#d0e202564">MPEP § 2128</a></b> -
                              <b><a href="s2128.html#d0e202804">§
                                    2128.02</a></b> for case law concerning public accessibility of
                              publications. 
                           </p>
                        </div>
                        <div class="Section">
                           <h2 class="section2" id="d0e203443">B.
                              &nbsp;&nbsp;Another’s Sale of a Product Made by a Secret Process Can Be
                              a Pre-AIA 35 U.S.C. 102(a) Public Use if the Process Can Be Determined by Examining
                              the Product
                           </h2>
                           <p id="d0e203450">“The nonsecret use of a claimed process in the usual
                              course of producing articles for commercial purposes is a public use.” But a secret
                              use of the process coupled with the sale of the product does not result in a public
                              use of the process unless the public could learn the claimed process by examining the
                              product. Therefore, secret use of a process by another, even if the product is
                              commercially sold, cannot result in a rejection under <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C.
                                    102(a)</a></b> if an examination of the product would not reveal the
                              process. <i>Id.</i></p>
                        </div>
                     </div>
                     <div class="Section">
                        <h2 class="section1" id="d0e203458">II.
                           &nbsp;&nbsp;“IN THIS COUNTRY”
                        </h2>
                        <div class="Section">
                           <h2 class="section2" id="d0e203462">
                              &nbsp;&nbsp;Only Knowledge or Use in the U.S. Can Be Used in a Pre-AIA
                              35&nbsp;U.S.C. 102(a) Rejection
                           </h2>
                           <p id="d0e203469">The knowledge or use relied on in a <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C.
                                    102(a)</a></b> rejection must be knowledge or use “in this country.”
                              Prior knowledge or use which is not present in the United States, even if widespread
                              in a foreign country, cannot be the basis of a rejection under <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35&nbsp;U.S.C.
                                    102(a)</a></b>. <i>In re</i><i>Ekenstam,</i> 256 F.2d 321, 118 USPQ 349 (CCPA 1958).
                              Note that the changes made to <b><a href="mpep-9015-appx-l.html#d0e302559">pre-AIA 35 U.S.C. 104</a></b> by NAFTA
                              (Public Law 103-182) and Uruguay Round Agreements Act (Public Law 103-465) do not
                              modify the meaning of “in this country” as used in <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C.
                                    102(a)</a></b> and thus “in this country” still means in the United
                              States for purposes of <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C. 102(a)</a></b>
                              rejections. 
                           </p>
                        </div>
                     </div>
                     <div class="Section">
                        <h2 class="section1" id="d0e203493">III.
                           &nbsp;&nbsp;“BY OTHERS”
                        </h2>
                        <div class="Section">
                           <h2 class="section2" id="d0e203497">
                              &nbsp;&nbsp;“Others” Means Any Combination of Authors or Inventors
                              Different Than the Inventive Entity
                           </h2>
                           <p id="d0e203501">The term “others” in <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C.
                                    102(a)</a></b> refers to any entity which is different from the
                              inventive entity. The entity need only differ by one person to be “by others.” This
                              holds true for all types of references eligible as prior art under <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C.
                                    102(a)</a></b> including publications as well as public knowledge and
                              use. Any other interpretation of <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C. 102(a)</a></b> “would
                              negate the one year [grace] period afforded under § 102(b).” <i>In re Katz,</i> 687 F.2d 450, 215 USPQ 14 (CCPA
                              1982).
                           </p>
                        </div>
                     </div>
                     <div class="Section">
                        <h2 class="section1" id="d0e203516">IV.
                           &nbsp;&nbsp;“PATENTED IN THIS OR A FOREIGN COUNTRY”
                        </h2>
                        <p id="d0e203524">See <b><a href="s2126.html#d0e202195">MPEP § 2126</a></b> for
                           information on the use of secret patents as prior art.
                        </p>
                     </div>
                     <div class="Section">
                        <h1 class="page-title" id="d0e203530">2132.01
                           &nbsp;&nbsp;Publications as Pre-AIA 35 U.S.C. 102(a) Prior Art  [R-11.2013]
                        </h1>
                        <p id="ch2100_d222e6_18b65_36c"><i>[Editor Note: This MPEP section is
                              <b id="">not applicable</b> to applications subject to examination under the first
                              inventor to file (FITF) provisions of the AIA as set forth in <b><a href="mpep-9015-appx-l.html#al_d1d917_1bef1_2b">35 U.S.C. 100
                                    (note)</a></b>. See <b><a href="s2159.html#ch2100_d20034_1dc34_1dd">MPEP §
                                    2159</a></b> et seq. to determine whether an application is subject
                              to examination under the FITF provisions, and <b><a href="s2150.html#ch2100_d2002f_22805_16e">MPEP §
                                    2150</a></b> et seq. for examination of applications subject to
                              those provisions. See <b><a href="s2152.html#ch2100_d20033_18e23_3ce">MPEP § 2152</a></b> et seq. for a detailed
                              discussion of <b><a href="mpep-9015-appx-l.html#al_d1fbe1_234ed_52">AIA 35 U.S.C. 102(a) and
                                    (b)</a></b>.]</i></p>
                        <div class="Section">
                           <h2 class="section1" id="d0e203537">I.
                              &nbsp;&nbsp;Pre-AIA 35 U.S.C. 102(a) <i>PRIMA FACIE</i> CASE
                              IS ESTABLISHED IF REFERENCE PUBLICATION IS “BY OTHERS”
                           </h2>
                           <p id="d0e203546">A <i>prima facie</i> case
                              is made out under <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C. 102(a)</a></b> if,
                              within 1 year of the filing date, the invention, or an obvious variant thereof, is
                              described in a “printed publication” whose authorship differs in any way from the
                              inventive entity unless it is stated within the publication itself that the
                              publication is describing the applicant’s work. <i>In re
                                 Katz,</i> 687 F.2d 450, 215&nbsp;USPQ 14 (CCPA 1982). See <b><a href="s2128.html#d0e202564">MPEP
                                    §&nbsp;2128</a></b> for case law on what constitutes a “printed
                              publication.” Note that when the reference is a U.S. patent published within the year
                              prior to the application filing date, a <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C.
                                    102(e)</a></b> rejection should be made. See <b><a href="s2136.html#d0e205544">MPEP §&nbsp;2136
                                    </a></b>- <b><a href="s2136.html#d0e206333">§ 2136.05</a></b> for case law dealing with
                              <b><a href="mpep-9015-appx-l.html#d0e302407">pre-AIA 35
                                    U.S.C. 102(e)</a></b>.
                           </p>
                        </div>
                        <div class="Section">
                           <h2 class="section1" id="d0e203570">II.
                              &nbsp;&nbsp;APPLICANT CAN REBUT <i>PRIMA FACIE</i> CASE BY
                              SHOWING REFERENCE’S DISCLOSURE WAS DERIVED FROM APPLICANT’S OWN WORK
                           </h2>
                           <p id="d0e203577">Applicant’s disclosure of his or her own work within the
                              year before the application filing date cannot be used against him or her under
                              <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C. 102(a)</a></b>. <i>In re
                                 Katz,</i> 687 F.2d 450, 215 USPQ 14 (CCPA 1982) (discussed below).
                              Therefore, where the applicant is one of the co-authors of a publication cited
                              against his or her application, the publication may be removed as a reference by the
                              filing of affidavits made out by the other authors establishing that the relevant
                              portions of the publication originated with, or were obtained from, applicant. Such
                              affidavits are called disclaiming affidavits.<i> Ex parte
                                 Hirschler,</i> 110 USPQ 384 (Bd. App. 1952). The rejection can also be
                              overcome by submission of a specific declaration by the applicant establishing that
                              the article is describing applicant’s own work. <i>In re
                                 Katz,</i> 687 F.2d 450, 215 USPQ 14 (CCPA 1982). However, if there is
                              evidence that the co-author has refused to disclaim inventorship and believes himself
                              or herself to be an inventor, applicant’s affidavit will not be enough to establish
                              that applicant is the sole inventor and the rejection will stand. <i>Ex parte Kroger,</i> 219 USPQ 370 (Bd. Pat. App. &amp; Int.
                              1982) (discussed below). It is also possible to overcome the rejection by adding the
                              coauthors as inventors to the application if the requirements of <b><a href="mpep-9015-appx-l.html#d0e302886">35 U.S.C.
                                    116</a></b>, third paragraph are met. <i>In
                                 re</i><i>Searles,</i> 422 F.2d 431, 164 USPQ 623 (CCPA
                              1970).
                           </p>
                           <p id="d0e203604">In <i>In re Katz,</i> 687
                              F.2d 450, 215 USPQ 14 (CCPA 1982), Katz stated in a declaration that the coauthors of
                              the publication, Chiorazzi and Eshhar, “were students working under the direction and
                              supervision of the inventor, Dr. David H. Katz.” The court held that this
                              declaration, in combination with the fact that the publication was a research paper,
                              was enough to establish Katz as the sole inventor and that the work described in the
                              publication was his own. In research papers, students involved only with assay and
                              testing are normally listed as coauthors but are not considered
                              co-inventors.
                           </p>
                           <p id="d0e203610">In <i>Ex parte Kroger,</i>
                              219 USPQ 370 (Bd. Pat. App. &amp; Inter. 1982), Kroger, Knaster and others were
                              listed as authors on an article on photovoltaic power generation. The article was
                              used to reject the claims of an application listing Kroger and Rod as inventors.
                              Kroger and Rod submitted affidavits declaring themselves to be the inventors. The
                              affidavits also stated that Knaster merely carried out assignments and worked under
                              the supervision and direction of Kroger. The Board stated that if this were the only
                              evidence in the case, it would be established, under <i>In re
                                 Katz,</i> that Kroger and Rod were the only inventors. However, in this
                              case, there was evidence that Knaster had refused to sign an affidavit disclaiming
                              inventorship and Knaster had introduced evidence into the case in the form of a
                              letter to the PTO in which he alleged that he was a co-inventor. The Board held that
                              the evidence had not been fully developed enough to overcome the rejection. Note that
                              the rejection had been made under <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C.
                                    102(f)</a></b> but the Board treated the issue the same as if it had
                              arisen under <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35 U.S.C. 102(a)</a></b>. See
                              also case law dealing with overcoming <b><a href="mpep-9015-appx-l.html#d0e302407">pre-AIA 35 U.S.C. 102(e)</a></b>
                              rejections as presented in <b><a href="s2136.html#d0e206333">MPEP § 2136.05</a></b>. Many of the issues
                              are the same.
                           </p>
                        </div>
                        <div class="Section">
                           <h2 class="section1" id="d0e203634">III.
                              &nbsp;&nbsp;A 37 CFR 1.131 AFFIDAVIT CAN BE USED TO OVERCOME A Pre-AIA
                              35 U.S.C. 102(a) REJECTION
                           </h2>
                           <p id="d0e203644">When the reference is not a statutory bar under
                              <b><a href="mpep-9015-appx-l.html#d0e302383">pre-AIA 35&nbsp;U.S.C. 102(b), (c), or (d)</a></b>, applicant can overcome
                              the rejection by swearing back of the reference through the submission of an
                              affidavit under <b><a href="mpep-0010-title-page.html#d0e323504">37 CFR 1.131</a></b>. <i>In re Foster,</i> 343 F.2d 980, 145 USPQ 166 (CCPA 1965).
                              If the reference is disclosing applicant’s own work as derived from him or her,
                              applicant may submit either a <b><a href="mpep-0010-title-page.html#d0e323504">37 CFR 1.131</a></b> affidavit to
                              antedate the reference or a <b><a href="mpep-9020-appx-r.html#d0e323552">37 CFR 1.132</a></b> affidavit to show
                              derivation of the reference subject matter from applicant and invention by applicant.
                              <i>In re Facius,</i> 408&nbsp;F.2d 1396, 161 USPQ 294
                              (CCPA 1969). See <b><a href="s715.html#d0e89737">MPEP §&nbsp;715</a></b> for more information on
                              when an affidavit under <b><a href="mpep-0010-title-page.html#d0e323504">37 CFR 1.131</a></b> can be used to
                              overcome a reference and what evidence is required.
                           </p>
                        </div>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s2101-2102.html">2101-2102-[Reserved]</a></li>
               <li xmlns=""><a href="s2103.html">2103-Patent Examination Process</a></li>
               <li xmlns=""><a href="s2104.html">2104-Patentable Subject Matter</a></li>
               <li xmlns=""><a href="s2105.html">2105-Patentable Subject Matter — Living Subject Matter</a></li>
               <li xmlns=""><a href="s2106.html">2106-Patent Subject Matter Eligibility</a><ul>
                     <li><a href="s2106.html#d0e198001">2106.01-Subject Matter Eligibility Analysis of Process Claims Involving Laws of Nature</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2107.html">2107-Guidelines for Examination of Applications for Compliance with the Utility Requirement</a><ul>
                     <li><a href="s2107.html#d0e198682">2107.01-General Principles Governing Utility Rejections</a></li>
                     <li><a href="s2107.html#d0e199419">2107.02-Procedural Considerations Related to Rejections for Lack of Utility</a></li>
                     <li><a href="s2107.html#d0e200058">2107.03-Special Considerations for Asserted Therapeutic or Pharmacological Utilities</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2108-2110.html">2108-2110-[Reserved]</a></li>
               <li xmlns=""><a href="s2111.html">2111-Claim Interpretation; Broadest Reasonable Interpretation</a><ul>
                     <li><a href="s2111.html#d0e200409">2111.01-Plain Meaning</a></li>
                     <li><a href="s2111.html#d0e200689">2111.02-Effect of Preamble</a></li>
                     <li><a href="s2111.html#d0e200824">2111.03-Transitional Phrases</a></li>
                     <li><a href="s2111.html#d0e201000">2111.04-“Adapted to,” “Adapted for,” “Wherein,” and “Whereby” Clauses</a></li>
                     <li><a href="s2111.html#ch2100_d1b148_1ea0c_2c0">2111.05-Functional and Nonfunctional Descriptive Material</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2112.html">2112-Requirements of Rejection Based on Inherency; Burden of Proof</a><ul>
                     <li><a href="s2112.html#d0e201273">2112.01-Composition, Product, and&nbsp; Apparatus Claims</a></li>
                     <li><a href="s2112.html#d0e201360">2112.02-Process Claims</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2113.html">2113-Product-by-Process Claims</a></li>
               <li xmlns=""><a href="s2114.html">2114-Apparatus and Article Claims — Functional Language</a></li>
               <li xmlns=""><a href="s2115.html">2115-Material or Article Worked Upon by Apparatus</a></li>
               <li xmlns=""><a href="s2116.html">2116-Material Manipulated in Process</a><ul>
                     <li><a href="s2116.html#d0e201660">2116.01-Novel, Unobvious Starting Material or End Product</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2117-2120.html">2117-2120-[Reserved]</a></li>
               <li xmlns=""><a href="s2121.html">2121-Prior Art; General Level of Operability Required to Make a Prima Facie Case</a><ul>
                     <li><a href="s2121.html#d0e201800">2121.01-Use of Prior Art in Rejections Where Operability is in Question</a></li>
                     <li><a href="s2121.html#d0e201868">2121.02-Compounds and Compositions — What Constitutes Enabling Prior Art</a></li>
                     <li><a href="s2121.html#d0e201937">2121.03-Plant Genetics — What Constitutes Enabling Prior Art</a></li>
                     <li><a href="s2121.html#d0e201980">2121.04-Apparatus and Articles — What Constitutes Enabling Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2122.html">2122-Discussion of Utility in the Prior Art</a></li>
               <li xmlns=""><a href="s2123.html">2123-Rejection Over Prior Art’s Broad Disclosure Instead of Preferred Embodiments</a></li>
               <li xmlns=""><a href="s2124.html">2124-Exception to the Rule That the Critical Reference Date Must Precede the Filing Date</a><ul>
                     <li><a href="s2124.html#ch2100_d1b13f_20224_b9">2124.01-Tax Strategies Deemed Within the Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2125.html">2125-Drawings as Prior Art</a></li>
               <li xmlns=""><a href="s2126.html">2126-Availability of a Document as a “Patent” for Purposes of Rejection Under 35 U.S.C. 102(a) or Pre-AIA 35 U.S.C. 102(a), (b),
                     and (d)</a><ul>
                     <li><a href="s2126.html#d0e202293">2126.01-Date of Availability of a Patent as a Reference</a></li>
                     <li><a href="s2126.html#d0e202334">2126.02-Scope of Reference’s Disclosure Which Can Be Used to Reject Claims When the Reference Is a “Patent” but Not a “Publication”</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2127.html">2127-Domestic and Foreign Patent Applications as Prior Art</a></li>
               <li xmlns=""><a href="s2128.html">2128-“Printed Publications” as Prior Art</a><ul>
                     <li><a href="s2128.html#d0e202706">2128.01-Level of Public Accessibility Required</a></li>
                     <li><a href="s2128.html#d0e202804">2128.02-Date Publication Is Available as a Reference</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2129.html">2129-Admissions as Prior Art</a></li>
               <li xmlns=""><a href="s2130.html">2130-[Reserved]</a></li>
               <li xmlns=""><a href="s2131.html">2131-Anticipation — Application of 35&nbsp;U.S.C. 102</a><ul>
                     <li><a href="s2131.html#d0e203057">2131.01-Multiple Reference 35 U.S.C. 102 Rejections</a></li>
                     <li><a href="s2131.html#d0e203166">2131.02-Genus-Species Situations</a></li>
                     <li><a href="s2131.html#d0e203269">2131.03-Anticipation of Ranges</a></li>
                     <li><a href="s2131.html#d0e203338">2131.04-Secondary Considerations</a></li>
                     <li><a href="s2131.html#d0e203351">2131.05-Nonanalogous or Disparaging Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2132.html">2132-Pre-AIA 35 U.S.C. 102(a)</a><ul>
                     <li><a href="s2132.html#d0e203530">2132.01-Publications as Pre-AIA 35 U.S.C. 102(a) Prior Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2133.html">2133-Pre-AIA 35 U.S.C. 102(b)</a><ul>
                     <li><a href="s2133.html#d0e203726">2133.01-Rejections of Continuation-In-Part (CIP) Applications</a></li>
                     <li><a href="s2133.html#d0e203739">2133.02-Rejections Based on Publications and Patents</a></li>
                     <li><a href="s2133.html#d0e203781">2133.03-Rejections Based on “Public Use” or “On Sale”</a><ul style="list-style-type: none">
                           <li><a href="s2133.html#d0e203899">2133.03(a)-“Public Use”</a></li>
                           <li><a href="s2133.html#d0e204201">2133.03(b)-“On Sale”</a></li>
                           <li><a href="s2133.html#d0e204494">2133.03(c)-The “Invention”</a></li>
                           <li><a href="s2133.html#d0e204651">2133.03(d)-“In This Country”</a></li>
                           <li><a href="s2133.html#d0e204670">2133.03(e)-Permitted Activity; Experimental Use</a><ul>
                                 <li><a href="s2133.html#d0e204712">2133.03(e)(1)-Commercial Exploitation</a></li>
                                 <li><a href="s2133.html#d0e204884">2133.03(e)(2)-Intent</a></li>
                                 <li><a href="s2133.html#d0e204900">2133.03(e)(3)-“Completeness” of the Invention</a></li>
                                 <li><a href="s2133.html#d0e204981">2133.03(e)(4)-Factors Indicative of an Experimental Purpose</a></li>
                                 <li><a href="s2133.html#d0e205019">2133.03(e)(5)-Experimentation and Degree of Supervision and Control</a></li>
                                 <li><a href="s2133.html#d0e205061">2133.03(e)(6)-Permitted Experimental Activity and Testing</a></li>
                                 <li><a href="s2133.html#d0e205133">2133.03(e)(7)-Activity of an Independent Third Party Inventor</a></li>
                              </ul>
                           </li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2134.html">2134-Pre-AIA 35 U.S.C. 102(c)</a></li>
               <li xmlns=""><a href="s2135.html">2135-Pre-AIA 35 U.S.C. 102(d)</a><ul>
                     <li><a href="s2135.html#d0e205339">2135.01-The Four Requirements of Pre-AIA 35 U.S.C. 102(d)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2136.html">2136-Pre-AIA 35 U.S.C. 102(e)</a><ul>
                     <li><a href="s2136.html#d0e205680">2136.01-Status of U.S. Application as a Reference</a></li>
                     <li><a href="s2136.html#d0e205829">2136.02-Content of the Prior Art Available Against the Claims</a></li>
                     <li><a href="s2136.html#d0e205924">2136.03-Critical Reference Date</a></li>
                     <li><a href="s2136.html#d0e206254">2136.04-Different Inventive Entity; Meaning of “By Another”</a></li>
                     <li><a href="s2136.html#d0e206333">2136.05-Overcoming a Rejection Under Pre-AIA 35&nbsp;U.S.C. 102(e)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2137.html">2137-Pre-AIA 35 U.S.C. 102(f)</a><ul>
                     <li><a href="s2137.html#d0e206713">2137.01-Inventorship</a></li>
                     <li><a href="s2137.html#d0e206972">2137.02-Applicability of Pre-AIA 35 U.S.C. 103(c)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2138.html">2138-Pre-AIA 35 U.S.C. 102(g)</a><ul>
                     <li><a href="s2138.html#d0e207148">2138.01-Interference Practice</a></li>
                     <li><a href="s2138.html#d0e207398">2138.02-“The Invention Was Made in This Country”</a></li>
                     <li><a href="s2138.html#d0e207478">2138.03-“By Another Who Has Not Abandoned, Suppressed, or Concealed It”</a></li>
                     <li><a href="s2138.html#d0e207607">2138.04-“Conception”</a></li>
                     <li><a href="s2138.html#d0e207753">2138.05-“Reduction to Practice”</a></li>
                     <li><a href="s2138.html#d0e207967">2138.06-“Reasonable Diligence”</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2139-2140.html">2139-2140-[Reserved]</a></li>
               <li xmlns=""><a href="s2141.html">2141-Examination Guidelines for Determining Obviousness Under 35 U.S.C. 103</a><ul>
                     <li><a href="s2141.html#d0e208803">2141.01-Scope and Content of the Prior Art</a><ul style="list-style-type: none">
                           <li><a href="s2141.html#d0e208985">2141.01(a)-Analogous and Nonanalogous Art</a></li>
                        </ul>
                     </li>
                     <li><a href="s2141.html#d0e209106">2141.02-Differences Between Prior Art and Claimed Invention</a></li>
                     <li><a href="s2141.html#d0e209300">2141.03-Level of Ordinary Skill in the Art</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2142.html">2142-Legal Concept of Prima Facie Obviousness</a></li>
               <li xmlns=""><a href="s2143.html">2143-Examples of Basic Requirements of a Prima Facie Case of Obviousness</a><ul>
                     <li><a href="s2143.html#d0e210245">2143.01-Suggestion or Motivation To Modify the References</a></li>
                     <li><a href="s2143.html#d0e210414">2143.02-Reasonable Expectation of Success Is Required</a></li>
                     <li><a href="s2143.html#d0e210501">2143.03-All Claim Limitations Must Be Considered</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2144.html">2144-Supporting a Rejection Under 35 U.S.C. 103</a><ul>
                     <li><a href="s2144.html#d0e210719">2144.01-Implicit Disclosure</a></li>
                     <li><a href="s2144.html#d0e210732">2144.02-Reliance on Scientific Theory</a></li>
                     <li><a href="s2144.html#d0e210752">2144.03-Reliance on Common Knowledge in the Art or “Well Known” Prior Art</a></li>
                     <li><a href="s2144.html#d0e210929">2144.04-Legal Precedent as Source of Supporting Rationale</a></li>
                     <li><a href="s2144.html#d0e211255">2144.05-Obviousness of Ranges</a></li>
                     <li><a href="s2144.html#d0e211480">2144.06-Art Recognized Equivalence for the Same Purpose</a></li>
                     <li><a href="s2144.html#d0e211558">2144.07-Art Recognized Suitability for an Intended Purpose</a></li>
                     <li><a href="s2144.html#d0e211596">2144.08-Obviousness of Species When Prior Art Teaches Genus</a></li>
                     <li><a href="s2144.html#d0e212153">2144.09-Close Structural Similarity Between Chemical Compounds (Homologs, Analogues, Isomers)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2145.html">2145-Consideration of Applicant’s Rebuttal Arguments</a></li>
               <li xmlns=""><a href="s2146.html">2146-Pre-AIA 35 U.S.C. 103(c)</a></li>
               <li xmlns=""><a href="s2147-2149.html">2147-2149-[Reserved]</a></li>
               <li xmlns=""><a href="s2150.html">2150-Examination Guidelines for 35 U.S.C. 102 and 103 as Amended by the First Inventor To File Provisions of the Leahy-Smith America
                     Invents Act</a></li>
               <li xmlns=""><a href="s2151.html">2151-Overview of the Changes to 35 U.S.C. 102 and 103 in the AIA</a></li>
               <li xmlns=""><a href="s2152.html">2152-Detailed Discussion of AIA 35 U.S.C. 102(a) and (b)</a><ul>
                     <li><a href="s2152.html#ch2100_d20033_1afb3_e6">2152.01-Effective Filing Date of the Claimed Invention</a></li>
                     <li><a href="s2152.html#ch2100_d20033_1d66c_1e5">2152.02-Prior Art Under AIA 35 U.S.C. 102(a)(1) (Patented, Described in a Printed Publication, or in Public Use, on Sale, or Otherwise
                           Available to the Public)</a><ul style="list-style-type: none">
                           <li><a href="s2152.html#ch2100_d20033_1d6c2_3b7">2152.02(a)-Patented</a></li>
                           <li><a href="s2152.html#ch2100_d20033_1da60_2e9">2152.02(b)-Described in a Printed Publication</a></li>
                           <li><a href="s2152.html#ch2100_d20033_1e416_252">2152.02(c)-In Public Use</a></li>
                           <li><a href="s2152.html#ch2100_d20033_2254b_3e0">2152.02(d)-On Sale</a></li>
                           <li><a href="s2152.html#ch2100_d20033_228c0_21c">2152.02(e)-Otherwise Available to the Public</a></li>
                           <li><a href="s2152.html#ch2100_d20033_232ba_27c">2152.02(f)-No Requirement of "By Others"</a></li>
                        </ul>
                     </li>
                     <li><a href="s2152.html#ch2100_d20033_23444_146">2152.03-Admissions</a></li>
                     <li><a href="s2152.html#ch2100_d20033_236db_f9">2152.04-The Meaning of "Disclosure"</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2153.html">2153-Prior Art Exceptions Under 35 U.S.C. 102(b)(1) to AIA 35 U.S.C. 102(a)(1)</a><ul>
                     <li><a href="s2153.html#ch2100_d20033_24caf_cd">2153.01-Prior Art Exception Under AIA 35 U.S.C. 102(b)(1)(A) To AIA 35 U.S.C. 102(a)(1) (Grace Period Inventor Or Inventor-Originated
                           Disclosure Exception)</a><ul style="list-style-type: none">
                           <li><a href="s2153.html#ch2100_d20033_24e66_2ac">2153.01(a)-Grace Period Inventor Disclosure Exception</a></li>
                           <li><a href="s2153.html#ch2100_d20033_256f4_147">2153.01(b)-Grace Period Inventor-Originated Disclosure Exception</a></li>
                        </ul>
                     </li>
                     <li><a href="s2153.html#ch2100_d20033_25935_125">2153.02-Prior Art Exception Under AIA 35 U.S.C. 102(b)(1)(B) to AIA 35 U.S.C. 102(a)(1) (Inventor Or Inventor-Originated Prior Public
                           Disclosure Exception)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2154.html">2154-Provisions Pertaining to Subject Matter in a U.S. Patent or Application Effectively Filed Before the Effective Filing Date
                     of the Claimed Invention</a><ul>
                     <li><a href="s2154.html#ch2100_d20033_27642_39b">2154.01-Prior Art Under AIA 35 U.S.C. 102(a)(2) “U.S. Patent Documents”</a><ul style="list-style-type: none">
                           <li><a href="s2154.html#ch2100_d20034_11f3b_a0">2154.01(a)-WIPO Published Applications</a></li>
                           <li><a href="s2154.html#ch2100_d20034_12188_300">2154.01(b)-Determining When Subject Matter Was Effectively Filed Under AIA 35 U.S.C. 102(d)</a></li>
                           <li><a href="s2154.html#ch2100_d20034_13884_7c">2154.01(c)-Requirement Of “Names Another Inventor”</a></li>
                        </ul>
                     </li>
                     <li><a href="s2154.html#ch2100_d20034_139ac_31b">2154.02-Prior Art Exceptions Under 35 U.S.C. 102(b)(2) to AIA 35 U.S.C. 102(a)(2)</a><ul style="list-style-type: none">
                           <li><a href="s2154.html#ch2100_d20034_13f89_241">2154.02(a)-Prior Art Exception Under AIA 35 U.S.C. 102(b)(2)(A) to AIA 35 U.S.C. 102(a)(2) (Inventor-Originated Disclosure Exception)</a></li>
                           <li><a href="s2154.html#ch2100_d20034_140df_1a6">2154.02(b)-Prior Art Exception Under AIA 35 U.S.C. 102(b)(2)(B) to AIA 35 U.S.C. 102(a)(2) (Inventor or Inventor-Originated Prior Public
                                 Disclosure Exception)</a></li>
                           <li><a href="s2154.html#ch2100_d20034_145f0_210">2154.02(c)-Prior Art Exception Under AIA 35 U.S.C. 102(b)(2)(C) to AIA 35 U.S.C. 102(a)(2) (Common Ownership or Obligation of Assignment)</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2155.html">2155-Use of Affidavits or Declarations Under 37 CFR 1.130 To Overcome Prior Art Rejections</a><ul>
                     <li><a href="s2155.html#ch2100_d20034_17271_83">2155.01-Showing That the Disclosure Was Made by the Inventor or a Joint Inventor</a></li>
                     <li><a href="s2155.html#ch2100_d20034_173e3_369">2155.02-Showing That the Subject Matter Disclosed Had Been Previously Publicly Disclosed by the Inventor or a Joint Inventor</a></li>
                     <li><a href="s2155.html#ch2100_d20034_1891a_11">2155.03-Showing That the Disclosure was Made, or That Subject Matter had Been Previously Publicly Disclosed, by Another Who Obtained
                           the Subject Matter Disclosed Directly or Indirectly From the Inventor or a Joint Inventor</a></li>
                     <li><a href="s2155.html#ch2100_d20034_19332_1dd">2155.04-Enablement</a></li>
                     <li><a href="s2155.html#ch2100_d20034_1b102_307">2155.05-Who May File an Affidavit or Declaration Under 37 CFR 1.130</a></li>
                     <li><a href="s2155.html#ch2100_d20034_1b27e_391">2155.06-Situations in Which an Affidavit or Declaration Is Not Available</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2156.html">2156-Joint Research Agreements</a></li>
               <li xmlns=""><a href="s2157.html">2157-Improper Naming of Inventors</a></li>
               <li xmlns=""><a href="s2158.html">2158-AIA 35 U.S.C. 103</a></li>
               <li xmlns=""><a href="s2159.html">2159-Applicability Date Provisions and Determining Whether an Application Is Subject to the First Inventor To File Provisions of
                     the AIA</a><ul>
                     <li><a href="s2159.html#ch2100_d20034_1dc9d_3c4">2159.01-Applications Filed Before March 16, 2013</a></li>
                     <li><a href="s2159.html#ch2100_d20034_1dfd4_279">2159.02-Applications Filed on or After March 16, 2013</a></li>
                     <li><a href="s2159.html#ch2100_d222e3_13adb_2f9">2159.03-Applications Subject to the AIA but Also Containing a Claimed Invention Having an Effective Filing Date Before March 16, 2013</a></li>
                     <li><a href="s2159.html#ch2100_d222e3_140d7_1bb">2159.04-Applicant Statement in Transition Applications Containing a Claimed Invention Having an Effective Filing Date on or After
                           March 16, 2013</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2160.html">2160-[Reserved]</a></li>
               <li xmlns=""><a href="s2161.html">2161-Three Separate Requirements for Specification Under 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, First Paragraph</a><ul>
                     <li><a href="s2161.html#d0e213447">2161.01-Computer Programming and 35 U.S.C. 112(a) or Pre-AIA 35&nbsp;U.S.C. 112, First Paragraph</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2162.html">2162-Policy Underlying 35 U.S.C. 112(a) or Pre-AIA 35 U.S.C. 112, First Paragraph</a></li>
               <li xmlns=""><a href="s2163.html">2163-Guidelines for the Examination of Patent Applications Under the 35 U.S.C. 112(a) or Pre-AIA 35&nbsp;U.S.C. 112, para. 1, “Written
                     Description” Requirement</a><ul>
                     <li><a href="s2163.html#d0e214533">2163.01-Support for the Claimed Subject Matter in Disclosure</a></li>
                     <li><a href="s2163.html#d0e214553">2163.02-Standard for Determining Compliance With the Written Description Requirement</a></li>
                     <li><a href="s2163.html#d0e214623">2163.03-Typical Circumstances Where Adequate Written Description Issue Arises</a></li>
                     <li><a href="s2163.html#d0e214731">2163.04-Burden on the Examiner with Regard to the Written Description Requirement</a></li>
                     <li><a href="s2163.html#d0e214820">2163.05-Changes to the Scope of Claims</a></li>
                     <li><a href="s2163.html#d0e215023">2163.06-Relationship of Written Description Requirement to New Matter</a></li>
                     <li><a href="s2163.html#d0e215099">2163.07-Amendments to Application Which Are Supported in the Original Description</a><ul style="list-style-type: none">
                           <li><a href="s2163.html#d0e215172">2163.07(a)-Inherent Function, Theory, or Advantage</a></li>
                           <li><a href="s2163.html#d0e215198">2163.07(b)-Incorporation by Reference</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2164.html">2164-The Enablement Requirement</a><ul>
                     <li><a href="s2164.html#d0e215268">2164.01-Test of Enablement</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e215360">2164.01(a)-Undue Experimentation Factors</a></li>
                           <li><a href="s2164.html#d0e215447">2164.01(b)-How to Make the Claimed Invention</a></li>
                           <li><a href="s2164.html#d0e215491">2164.01(c)-How to Use the Claimed Invention</a></li>
                        </ul>
                     </li>
                     <li><a href="s2164.html#d0e215531">2164.02-Working Example</a></li>
                     <li><a href="s2164.html#d0e215634">2164.03-Relationship of Predictability of the Art and the Enablement Requirement</a></li>
                     <li><a href="s2164.html#d0e215702">2164.04-Burden on the Examiner Under the Enablement Requirement</a></li>
                     <li><a href="s2164.html#d0e215797">2164.05-Determination of Enablement Based on Evidence as a Whole</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e215860">2164.05(a)-Specification Must Be Enabling as of the Filing Date</a></li>
                           <li><a href="s2164.html#d0e215949">2164.05(b)-Specification Must Be Enabling to Persons Skilled in the Art</a></li>
                        </ul>
                     </li>
                     <li><a href="s2164.html#d0e215984">2164.06-Quantity of Experimentation</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e216038">2164.06(a)-Examples of Enablement Issues-Missing Information</a></li>
                           <li><a href="s2164.html#d0e216163">2164.06(b)-Examples of Enablement Issues — Chemical Cases</a></li>
                           <li><a href="s2164.html#d0e216273">2164.06(c)-Examples of Enablement Issues – Computer Programming Cases</a></li>
                        </ul>
                     </li>
                     <li><a href="s2164.html#d0e216498">2164.07-Relationship of Enablement Requirement to Utility Requirement of 35 U.S.C. 101</a></li>
                     <li><a href="s2164.html#d0e216700">2164.08-Enablement Commensurate in Scope With the Claims</a><ul style="list-style-type: none">
                           <li><a href="s2164.html#d0e216855">2164.08(a)-Single Means Claim</a></li>
                           <li><a href="s2164.html#d0e216871">2164.08(b)-Inoperative Subject Matter</a></li>
                           <li><a href="s2164.html#d0e216899">2164.08(c)-Critical Feature Not Claimed</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2165.html">2165-The Best Mode Requirement</a><ul>
                     <li><a href="s2165.html#d0e216999">2165.01-Considerations Relevant to Best Mode</a></li>
                     <li><a href="s2165.html#d0e217148">2165.02-Best Mode Requirement Compared to Enablement Requirement</a></li>
                     <li><a href="s2165.html#d0e217195">2165.03-Requirements for Rejection for Lack of Best Mode</a></li>
                     <li><a href="s2165.html#d0e217264">2165.04-Examples of Evidence of Concealment</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2166-2170.html">2166-2170-[Reserved]</a></li>
               <li xmlns=""><a href="s2171.html">2171-Two Separate Requirements for Claims Under 35 U.S.C. 112 (b) or Pre-AIA 35 U.S.C. 112, Second Paragraph</a></li>
               <li xmlns=""><a href="s2172.html">2172-Subject Matter Which the Inventor or a Joint Inventor Regards as The Invention</a><ul>
                     <li><a href="s2172.html#d0e217526">2172.01-Unclaimed Essential Matter</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2173.html">2173-Claims Must Particularly Point Out and Distinctly Claim the Invention</a><ul>
                     <li><a href="s2173.html#d0e217578">2173.01-Interpreting the Claims</a></li>
                     <li><a href="s2173.html#d0e217598">2173.02-Determining Whether Claim Language is Definite</a></li>
                     <li><a href="s2173.html#d0e217747">2173.03-Correspondence Between Specification and Claims</a></li>
                     <li><a href="s2173.html#d0e217778">2173.04-Breadth Is Not Indefiniteness</a></li>
                     <li><a href="s2173.html#d0e217809">2173.05-Specific Topics Related to Issues Under 35 U.S.C. 112(b) or Pre-AIA 35 U.S.C. 112, Second Paragraph</a><ul style="list-style-type: none">
                           <li><a href="s2173.html#d0e217839">2173.05(a)-New Terminology</a></li>
                           <li><a href="s2173.html#d0e217939">2173.05(b)-Relative Terminology</a></li>
                           <li><a href="s2173.html#d0e218152">2173.05(c)-Numerical Ranges and Amounts Limitations</a></li>
                           <li><a href="s2173.html#d0e218251">2173.05(d)-Exemplary Claim Language (“for example,” “such as”)</a></li>
                           <li><a href="s2173.html#d0e218320">2173.05(e)-Lack of Antecedent Basis</a></li>
                           <li><a href="s2173.html#d0e218380">2173.05(f)-Reference to Limitations in Another Claim</a></li>
                           <li><a href="s2173.html#d0e218409">2173.05(g)-Functional Limitations</a></li>
                           <li><a href="s2173.html#d0e218467">2173.05(h)-Alternative Limitations</a></li>
                           <li><a href="s2173.html#d0e218588">2173.05(i)-Negative Limitations</a></li>
                           <li><a href="s2173.html#d0e218640">2173.05(j)-Old Combination</a></li>
                           <li><a href="s2173.html#d0e218715">2173.05(k)-Aggregation</a></li>
                           <li><a href="s2173.html#">2173.05(l)-[Reserved]</a></li>
                           <li><a href="s2173.html#d0e218748">2173.05(m)-Prolix</a></li>
                           <li><a href="s2173.html#d0e218755">2173.05(n)-Multiplicity</a></li>
                           <li><a href="s2173.html#d0e218827">2173.05(o)-Double Inclusion</a></li>
                           <li><a href="s2173.html#d0e218855">2173.05(p)-Claim Directed to Product-By- Process or Product and Process</a></li>
                           <li><a href="s2173.html#d0e218952">2173.05(q)-“Use” Claims</a></li>
                           <li><a href="s2173.html#d0e219030">2173.05(r)-Omnibus Claim</a></li>
                           <li><a href="s2173.html#d0e219061">2173.05(s)-Reference to Figures or Tables</a></li>
                           <li><a href="s2173.html#d0e219080">2173.05(t)-Chemical Formula</a></li>
                           <li><a href="s2173.html#d0e219126">2173.05(u)-Trademarks or Trade Names in a Claim</a></li>
                           <li><a href="s2173.html#d0e219164">2173.05(v)-Mere Function of Machine</a></li>
                        </ul>
                     </li>
                     <li><a href="s2173.html#d0e219183">2173.06-Practice Compact Prosecution</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s2174.html">2174-Relationship Between the Requirements of 35 U.S.C. 112(a) and (b) or Pre-AIA 35 U.S.C. 112, First and Second Paragraphs</a></li>
               <li xmlns=""><a href="s2175-2180.html">2175-2180-[Reserved]</a></li>
               <li xmlns=""><a href="s2181.html">2181-Identifying and Interpreting a 35 U.S.C. 112(f) or Pre-AIA 35 U.S.C. 112, Sixth Paragraph Limitation</a></li>
               <li xmlns=""><a href="s2182.html">2182-Search and Identification of the Prior Art</a></li>
               <li xmlns=""><a href="s2183.html">2183-Making a Prima Facie Case of Equivalence</a></li>
               <li xmlns=""><a href="s2184.html">2184-Determining Whether an Applicant Has Met the Burden of Proving Nonequivalence After a Prima Facie Case Is Made</a></li>
               <li xmlns=""><a href="s2185.html">2185-Related Issues Under 35 U.S.C. 112(a) or (b) and Pre-AIA 35 U.S.C. 112, First or Second Paragraphs</a></li>
               <li xmlns=""><a href="s2186.html">2186-Relationship to the Doctrine of Equivalents</a></li>
               <li xmlns=""><a href="s2187-2189.html">2187-2189-[Reserved]</a></li>
               <li xmlns=""><a href="s2190.html">2190-Prosecution Laches</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      <!-- Footer Navigation: /includes/general/footer2.html -->

<!-- Used in: MPEP, CPC -->

<!-- ID = $Id: footer2.html 3354 2013-04-23 18:43:33Z janaki $ -->

<!-- URL = $URL: https://dev-wmb-svn.etc.uspto.gov/repos/live/active_content/trunk/includes/general/footer2.html $ -->





  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:33 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>